Government ❯ Health Policy

Regulatory Agencies

FDA Anvisa ANMAT Drug Regulation Health Regulations Health Recommendations Drug Approval ANVISA Food and Drug Administration Cofepris

HHS Confirms FDA Halted Studies Finding COVID and Shingles Vaccines Safe

The move intensifies concerns about political interference in vaccine science.

Japan Orders Fukuoka Stem-Cell Clinic to Halt Treatments Under Emergency Safety Law

UK Pharmacies Report Cloned Websites Pushing Fake Weight-Loss Jabs as Trade Body Urges Crackdown

Victims’ Group Presses Shiseido and Japan to Probe Asbestos Risk in Talc Cosmetics

Australia Begins Permanently Listing Health Practitioners’ Sexual Misconduct on Public Register

Saskatchewan Cuts Funding and Contracts With Prairie Harm Reduction After Federal Suspension

OPS Opens Regional Procurement to Argentine Drugmakers With First Major Vaccine Deal

Paris Region Suspends Four Inpatient Child Psychiatry Units at Fondation Vallée From Feb. 27

Brazil Weighs Tirzepatide Access: New Bill Seeks Farmácia Popular Coverage as Patent‑Break Push Advances

Japan Orders Reforms at Tokyo Regenerative Clinic Over Unapproved Drug Mixing and Unreported Harms

Bhattacharya Poised to Lead CDC as Acting Director After Year of RFK Jr. Upheaval

Mexican Court Revives Denosumab Patent, Extends Amgen Exclusivity to 2027

FDA Rejects Filing of Moderna’s mRNA Flu Vaccine Over Comparator Dispute

24 Families File Paris Complaint in Infant-Formula Toxin Scandal

Peru and Mexico Order Precautionary Recall of Alula Gold Infant Formulas Over Toxin Alert

Brazil Advances Injectable HIV PrEP Rollout, Explores Local Production After Fiocruz–Gilead Memorandum

HHS Opens Review of Cellphone Radiation Risks as FDA Pulls Old Safety Pages

Kennedy Appoints Two OB-GYNs to CDC Vaccine Panel, Extending Overhaul of ACIP

Brazil Authorizes First Human Trial of UFRJ’s Polilaminina for Acute Spinal Cord Injury

Investigation Finds Banned Insulin Still Dispensed in Peru Despite Recall Order